Xu Shi

3.5k total citations
31 papers, 1.2k citations indexed

About

Xu Shi is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Xu Shi has authored 31 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 7 papers in Cardiology and Cardiovascular Medicine and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Xu Shi's work include Metabolomics and Mass Spectrometry Studies (9 papers), Diet and metabolism studies (4 papers) and Liver Disease Diagnosis and Treatment (4 papers). Xu Shi is often cited by papers focused on Metabolomics and Mass Spectrometry Studies (9 papers), Diet and metabolism studies (4 papers) and Liver Disease Diagnosis and Treatment (4 papers). Xu Shi collaborates with scholars based in United States, China and United Kingdom. Xu Shi's co-authors include Robert E. Gerszten, Hasmik Keshishian, Marc S. Sabatine, Steven A. Carr, D.R. Mani, Michael Burgess, Terri A. Addona, Laurie Farrell, Eric Kuhn and Dongxiao Shen and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Nature Communications.

In The Last Decade

Xu Shi

31 papers receiving 1.2k citations

Peers

Countries citing papers authored by Xu Shi

Since Specialization

Citations

This map shows the geographic impact of Xu Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xu Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xu Shi more than expected).

Fields of papers citing papers by Xu Shi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xu Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xu Shi. The network helps show where Xu Shi may publish in the future.

Co-authorship network of co-authors of Xu Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Xu Shi. A scholar is included among the top collaborators of Xu Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xu Shi. Xu Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Circulating Metabolite Biomarkers of Glycemic Control in Youth-Onset Type 2 Diabetes 2024 ·Diabetes Care ·Zsu‐Zsu Chen, Chang Lu, Jonathan M. Dreyfuss, (unknown), Xu Shi, Shuning Zheng, (unknown), Laura Pyle, Petter Bjornstad, Laure El ghormli, Robert E. Gerszten, Elvira Isganaitis	1
2	ER Stress-Perturbed Intracellular Protein O-GlcNAcylation Aggravates Podocyte Injury in Diabetes Nephropathy 2023 ·International Journal of Molecular Sciences ·(unknown), Tiantian Hu, Xu Shi, (unknown), Sirui Liu, Xue Li, Wei Zou, Cheng Wang	6
3	Genetic modifiers modulate phenotypic expression of tafazzin deficiency in a mouse model of Barth syndrome 2023 ·Human Molecular Genetics ·Suya Wang, (unknown), (unknown), (unknown), (unknown), (unknown), Haiyan Wu, Xu Yang, Xu Shi, Douglas Strathdee, Robert E. Gerszten, Michael Schlame, William T. Pu	10
4	CYP4F2 is a human-specific determinant of circulating N-acyl amino acid levels 2023 ·Journal of Biological Chemistry ·Julia T. Tanzo, (unknown), Amanda L. Wiggenhorn, María Dolores Moya-Garzón, Wei Wei, Xuchao Lyu, Wentao Dong, Usman A. Tahir, Zsu‐Zsu Chen, Daniel E. Cruz, Shuliang Deng, Xu Shi, Shuning Zheng, Yan Guo, Mario Sims, Monther Abu-Remaileh, James G. Wilson, Robert E. Gerszten, Jonathan Z. Long, Mark D. Benson	3
5	Mixed meal tolerance testing highlights in diabetes altered branched-chain ketoacid metabolism and pathways associated with all-cause mortality 2023 ·American Journal of Clinical Nutrition ·Michael Mi, Mark Whitlock, Xu Shi, Laurie Farrell, (unknown), (unknown), Matthew Blatnik, (unknown), (unknown), Albert Kim, Peter T. Loudon, Zsu‐Zsu Chen, Adolfo Correa, Yan Gao, April P. Carson, Alain G. Bertoni, Rachel J. Roth Flach, Robert E. Gerszten	2
6	Plasma metabolomic signatures of obesity and risk of type 2 diabetes 2022 ·Obesity ·Xiong‐Fei Pan, Zsu‐Zsu Chen, Thomas J. Wang, Xiang Shu, Hui Cai, Qiuyin Cai, Clary B. Clish, Xu Shi, Wei Zheng, Robert E. Gerszten, Xiao‐Ou Shu, Danxia Yu	8
7	The choline transporter Slc44a2 controls platelet activation and thrombosis by regulating mitochondrial function 2020 ·Nature Communications ·(unknown), Michael A. Mastrangelo, Sara Ture, Charles O. Smith, (unknown), (unknown), Xu Shi, Ryan M. Burke, Sherry L. Spinelli, Scott J. Cameron, Thomas E. Carey, Paul S. Brookes, Robert E. Gerszten, Maria Sabater‐Lleal, Paul S. de Vries, Jennifer E. Huffman, Nicholas L. Smith, Craig N. Morrell, Charles J. Lowenstein	56
8	Changes in Citric Acid Cycle and Nucleoside Metabolism Are Associated with Anthracycline Cardiotoxicity in Patients with Breast Cancer 2019 ·Journal of Cardiovascular Translational Research ·Aarti Asnani, Xu Shi, Laurie Farrell, Rahul K. Lall, Igal A. Sebag, Juan Carlos Plana, Robert E. Gerszten, Marielle Scherrer‐Crosbie	32
9	Percutaneous vertebroplasty versus non-operative treatment for osteoporotic vertebral compression fractures: a meta-analysis of randomized controlled trials 2019 ·Osteoporosis International ·Shenghan Lou, Xu Shi, (unknown), Houchen Lyu, (unknown), (unknown)	45
10	Clinical Metabolomics Identifies Blood Serum Branched Chain Amino Acids as Potential Predictive Biomarkers for Chronic Graft vs. Host Disease 2019 ·Frontiers in Oncology ·Marcos Rodrigo Alborghetti, Maria Elvira Pizzigatti Corrêa, Jennifer Whangbo, Xu Shi, Juliana A. Aricetti, (unknown), Eliana Miranda, Maurício L. Sforça, Camila Caldana, Robert E. Gerszten, Jerome Ritz, Ana Carolina de Mattos Zeri	17
11	Identification of specific metabolic pathways as druggable targets regulating the sensitivity to cyanide poisoning 2018 ·PLoS ONE ·Patrick Sips, Xu Shi, Gabriel Musso, Anjali K. Nath, Yanbin Zhao, (unknown), Jordan Morningstar, (unknown), (unknown), (unknown), Vikhyat S. Bebarta, Jared Rutter, V. Jo Davisson, Sari Mahon, Matthew Brenner, Gerry R. Boss, Randall T. Peterson, Robert E. Gerszten, Calum A. MacRae	13
12	l-Alanine activates hepatic AMP-activated protein kinase and modulates systemic glucose metabolism 2018 ·Molecular Metabolism ·Yusuke Adachi, Ana Luísa De Sousa‐Coelho, (unknown), (unknown), Sandra Weimer, Xu Shi, Karina N. Gonzalez Herrera, Hirokazu Takahashi, (unknown), Yasushi Noguchi, Laurie J. Goodyear, Marcia C. Haigis, Robert E. Gerszten, Mary‐Elizabeth Patti	41
13	Cisplatin Analogs Confer Protection against Cyanide Poisoning 2017 ·Cell chemical biology ·Anjali K. Nath, Xu Shi, Devin Harrison, Jordan Morningstar, Sari Mahon, Adriano Chan, Patrick Sips, Jangwoen Lee, Calum A. MacRae, Gerry R. Boss, Matthew Brenner, Robert E. Gerszten, Randall T. Peterson	19
14	HELZ2 Is an IFN Effector Mediating Suppression of Dengue Virus 2017 ·Frontiers in Microbiology ·Dahlene N. Fusco, Henry Pratt, (unknown), (unknown), Wenyu Lin, (unknown), Megha Basavappa, Kate L. Jeffrey, Anthony Anselmo, Ruslan I. Sadreyev, Clarence Yapp, Xu Shi, John O’Sullivan, Robert E. Gerszten, Takuya Tomaru, Satoshi Yoshino, Tetsurou Satoh, Raymond T. Chung	35
15	Metabolite profiling identifies anandamide as a biomarker of nonalcoholic steatohepatitis 2017 ·JCI Insight ·W. Taylor Kimberly, John O’Sullivan, Anjali K. Nath, Michelle J. Keyes, Xu Shi, Martin G. Larson, Qiong Yang, Michelle T. Long, Ramachandran S. Vasan, Randall T. Peterson, Thomas J. Wang, Kathleen E. Corey, Robert E. Gerszten	54
16	CHANGES IN CITRIC ACID METABOLISM ARE ASSOCIATED WITH THE DEVELOPMENT OF ANTHRACYCLINE-INDUCED CARDIOTOXICITY IN MICE AND IN PATIENTS 2017 ·Journal of the American College of Cardiology ·Aarti Asnani, Xu Shi, Laurie Farrell, Robert E. Tainsh, Sara Vandenwijngaert, Kai‐Hung Cheng, Emmanuel S. Buys, Robert E. Gerszten, Marielle Scherrer‐Crosbie	1
17	Restenosis Inhibition and Re-differentiation of TGFβ/Smad3-activated Smooth Muscle Cells by Resveratrol 2017 ·Scientific Reports ·Yichen Zhu, Toshio Takayama, Bowen Wang, (unknown), Mengxue Zhang, Bernard Y.K. Binder, Go Urabe, Yatao Shi, Daniel DiRenzo, Shakti A. Goel, Yifan Zhou, Christopher J. Little, Drew A. Roenneburg, Xu Shi, Lingjun Li, William L. Murphy, K. Craig Kent, (unknown), Lian‐Wang Guo	24
18	A pipeline that integrates the discovery and verification of plasma protein biomarkers reveals candidate markers for cardiovascular disease 2011 ·Nature Biotechnology ·Terri A. Addona, Xu Shi, Hasmik Keshishian, D.R. Mani, Michael Burgess, Michael A. Gillette, Karl R. Clauser, Dongxiao Shen, Gregory D. Lewis, Laurie Farrell, Michael A. Fifer, Marc S. Sabatine, Robert E. Gerszten, Steven A. Carr	192
19	Quantification of Cardiovascular Biomarkers in Patient Plasma by Targeted Mass Spectrometry and Stable Isotope Dilution 2009 ·Molecular & Cellular Proteomics ·Hasmik Keshishian, Terri A. Addona, Michael Burgess, D.R. Mani, Xu Shi, Eric Kuhn, Marc S. Sabatine, Robert E. Gerszten, Steven A. Carr	233
20	Performance characteristics of an FT MS‐based workflow for label‐free differential MS analysis of human plasma: standards, reproducibility, targeted feature investigation, and application to a model of controlled myocardial infarction 2008 ·PROTEOMICS - CLINICAL APPLICATIONS ·Jennifer N. Sutton, (unknown), Xu Shi, Michael Athanas, (unknown), Robert E. Gerszten, Leo E. Bonilla	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact